Discover an informative webinar focusing on the pivotal role of apheresis in sourcing high-quality starting material for cellular therapies.
As the landscape of regenerative medicine continues to evolve, understanding the intricacies of apheresis becomes increasingly vital. In this webinar, the expert presenters will guide you through the apheresis procedure, emphasizing its significance in the collection of cellular components necessary for therapies like CAR T-cell treatments and stem cell transplants, detailing donor sourcing patient treatment considerations.
They will also highlight how apheresis-based bone marrow transplantation and donor programs can enhance or advance hospital programs, bolstering reputation and serving more patients. Moreover, they will cover the critical role that skilled nurses play in ensuring the safety and comfort of both patients and donors during the process and underscore how expertise not only enhances the patient experience but also directly impacts the quality of the collected material.
With a focus on quality, the expert speakers will then describe the impact of adherence to collection protocols and the real-world implications for treatment outcomes. Attendees will learn how subtle differences in the apheresis process can lead to significant discrepancies in the cellular products, ultimately affecting the efficacy of the therapies derived from them.
Finally, they will discuss the importance of selecting qualified practitioners for apheresis procedures and the criteria for evaluating practitioner expertise as well as systems that ensure optimal results.
Register for this webinar today to understand the role of apheresis in sourcing high-quality starting materials for cellular therapies like CAR T-cell treatments and stem cell transplants.
Speakers
Carolina Betancourt, RN, Executive Director, Clinical Apheresis and Cellular Therapy, Comprehensive Cell Solutions
Carolina Betancourt is the Executive Director of Clinical Apheresis and Cellular Therapy. Carolina is a registered nurse who holds a license in the State of New York and New Jersey. She is highly experienced in clinical focus since 2007. Carolina’s career at NYBC started in 2013 as an apheresis RN.
In 2018, she took the role of RN Manager and more recently acquired the position of Director for the Apheresis Teams across the enterprise. She has extensive knowledge in cellular therapy collections as well as therapeutic procedures. Carolina participated in the development of NYBCe’s electronic scheduling and procedural documentation system. Carolina is a member of the American Society of Apheresis.
Message Presenter
Stephanie Dormesy, MPH, Senior Director, Cell Sourcing Partnerships, Comprehensive Cell Solutions
Stephanie Dormesy serves as the Senior Director of Cell Sourcing Partnerships at Comprehensive Cell Solutions (CCS) — the CDMO business unit of New York Blood Center Enterprises (NYBCe). As a Public Health Professional with expertise in donor management and apheresis collections, Stephanie focuses on the successful execution of donor cell collection (i.e. whole blood, T-Cells, stem cells) for both research use and clinical and commercial phase products.
Stephanie’s career at NYBC started in 2013 as a Clinical Trial Coordinator. In 2014, she transitioned to the role of Apheresis Manager and has significantly grown apheresis collections and donor management for cellular therapy activity within CCS. She currently utilizes her skills and 13-year healthcare management background to provide oversight, leadership and guidance in the management of donors and execution of clinical research for NMDP, NMDP Biotherapies and various other biopharmaceutical clients.
Stephanie earned a Master of Public Health with a concentration in Epidemiology from SUNY Downstate Medical Center and a Bachelor of Arts in Sociology from New York University.
Message PresenterWho Should Attend?
This webinar will appeal to:
- Researchers who regularly procure cellular starting material
- Clinical stage developers of autologous and allogeneic cellular therapies
- Hospital administrators who are looking to expand into cell therapy and/or clinical apheresis programs
- Anyone who wants to learn about apheresis and its role in advanced medicines
What You Will Learn
Attendees will learn about:
- The role of apheresis collections in advanced cell-based therapeutics
- Variations in apheresis protocols and the importance of standardization
- Considerations for comfort and quality for donors and patients
Xtalks Partner
Comprehensive Cell Solutions
Founded in 2003 as a business unit of New York Blood Center Enterprises, CCS offers its deep expertise in the development and manufacture of cell and gene therapies, using its GMP and GTP facilities. CCS provides a true vein-to-vein solution, spanning fresh cellular collections and cord blood-derived stem cells as source material, to cell isolation, manipulation and cryopreservation capabilities for preclinical to commercial stage products. CCS boasts a client roster comprised of the world’s leading pharmaceutical companies, innovative biotechnology organizations, and academic medical centers. CCS maintains its headquarters in New York City, where it offers its full service CDMO capabilities from cellular collections and clinical apheresis through manufacturing and cryopreservation. Additional collection suites, apheresis services, and development and manufacturing operations are offered at sites in Providence, RI, Kansas City, MO, St. Paul, MN, Houston, TX and Louisville, KY.
You Must Login To Register for this Free Webinar
Already have an account? LOGIN HERE. If you don’t have an account you need to create a free account.
Create Account